INSIGHTS ON DRUG DEVELOPMENT
-
Molecular Properties Of PROTACs And The Relationship To Formulation Design
Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development
Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
Transforming Research Through Lab Automation
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
-
Little Patients, Big Challenges: Developing Pediatric Formulations
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?11/13/2024
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
How Automation Helps Life Sciences Manufacturers Deliver Faster, Safer Therapies6/2/2026
Automation paired with smart data management is becoming the base for faster drug and vaccine production without trading away quality. Five investment priorities show where manufacturers are concentrating their efforts.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era4/21/2026
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
Managing The Challenges Of Controlled Substance Manufacturing9/22/2026
How can manufacturers balance security, compliance, and supply continuity in controlled substance development and production?
-
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins8/27/2026
Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
DRUG DEVELOPMENT SOLUTIONS
-
Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.
-
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
-
Understand Your Biotransformation Data
MetaSense helps you make sense of all your metabolite identification (MetID) data. Move beyond complex workflows that have you flipping back and forth between a dozen programs.
With a single interface for prediction, data analysis, and knowledge dashboards, make data-driven decisions swiftly.
- Collect all your MetID data and view it in one place
- Auto-generate biotransformation maps and kinetic plots
- Click between interactively linked maps and plots to see your data at any depth
- Reprocess data directly from MetaSense
- Draw conclusions about a drug candidate’s metabolism and viability
-
Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.
-
What is dissolution testing? Why is it critical? What should you consider for your method validation? Find answers to these questions and more in this quick guide to dissolution testing.